Dataset opportunity
Maslanka — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Maslanka, usable for Regulatory RAG and Compliance Copilots.
Score
47.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Medical Device Regulatory Affairs market = $7.49B in 2025, CAGR 9.69%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
Continuous investment in R&D and product development mentioned as a core pillar
source ↗
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — licensing rights to clarify
Buyer persona
RegTech & compliance-AI vendors
Maslanka holds a specialized Regulatory Records Dataset in text modality, containing proprietary medical device designs, patents, and documentation compliant with Medical Device Regulation (MDR) standards. This structured collection of industrial_data and business records is exceptionally suited for developing a Regulatory RAG system, enabling precise, evidence-based answers to complex compliance and development queries.
The business value of such data is highlighted by the global Medical Device Regulatory Affairs market, which was valued at USD 7.49 Billion in 2025 and is projected to grow at a CAGR of 9.69%. [2] Despite access complexities like confidentiality agreements and proprietary designs, this dataset is highly valuable as it provides a rare, real-world foundation for building AI tools to navigate the increasingly complex and lucrative medical device compliance landscape. ⚠ Diligence (valuable data, access to negotiate): Data involves proprietary medical device designs and patents; Subject to Medical Device Regulation (MDR) documentation standards; Potential confidentiality agreements with OEM partners for kundenspezifische Entwicklungen · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively demonstrates Maslanka's ownership of proprietary data spanning the entire medical device product lifecycle, from initial R&D and patent filings to in-house manufacturing. This unique, high-rarity dataset is a critical asset for RegTech and compliance-AI vendors seeking to build advanced Regulatory RAG models. In a medical device regulatory market projected to reach $7.49 billion by 2025, this data offers a distinct competitive advantage by providing the ground-truth needed to train sophisticated AI solutions for navigating complex compliance pathways.
See dimension details ↓- Dataset Specificity78
dominant 'regulatory', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
AI buyer demand is high, driven by the need for specialized data to build solutions for the complex Medical Device Regulatory Affairs market, which is expanding at a 9.69% CAGR. [2]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
ownership=company_owned, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
surplus=medium — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit58
⚠ review — The company manufactures and sells physical medical instruments for endoscopy, it does not appear to have a 'Regulatory Records Dataset' or any other data-based product. Issues: The company's core business is manufacturing and selling physical goods (surgical instruments), not services that would generate dormant data as a by-product. [; The initial prompt's description 'Regulatory Records Dataset Opportunity' is a complete mismatch with the company's actual business of medical device manufactur; There is no evidence that the company holds or generates any significant datasets beyond standard operational business data (sales, production, etc.).
- Deep Qualification80
✓ pass — Maslanka is a manufacturer of medical instruments that also provides custom development for other companies, making the existence of a regulatory dataset plausible but its ownership mixed between proprietary and client-owned IP.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
This evidence indicates a deep archive of longitudinal R&D data, including decades of patent filings and continuous product development records, which is invaluable for training AI to understand technological evolution.
business_records
This evidence confirms the existence of records detailing customer-specific product developments with major MedTech partners, providing real-world data on commercial collaborations and market standards.
Regulatory records
This evidence demonstrates proprietary data covering the end-to-end manufacturing process, from in-house tooling design to the finished medical product, which is essential for building Regulatory RAG systems that can trace a product's full compliance journey.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Maslanka Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global Medical Device Regulatory Affairs market = $7.49B in 2025, CAGR 9.69% (source: Spherical Insights). Investment score 47.5/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
13Therapeutics — Можливість отримання набору медичних зображень
View opportunity →охорона здоров'яComprehensivesleepcare — Можливість отримання набору медичних зображень
View opportunity →охорона здоров'яKardium — Можливість отримання набору медичних зображень
View opportunity →Data Academy
Learn before you deal
- Ринки даних: пояснення4 min read
- Ліцензування даних, термін за терміном4 min read
- Чи ваші дані коштують грошей?3 min read